ScreenerHero
PCLOPharmaCielo Ltd.
TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · pharmacielo.com
0.0700CAD+16.67%Mkt Cap: 9.58M $P/E: —

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetra…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap9.58M $
Enterprise Value23.98M $
Revenue (TTM)1.85M $
Gross Profit528.14K $
Net Income (TTM)-2.61M $
Revenue/Share0.0095 USD
Last Price0.0700 CAD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.40
PEG—
EV/EBITDA-18.45
EV/Revenue12.98
P/S5.52
P/B-1.27
EPS (TTM)-0.02
EPS (Forward)-0.05
52W Range
0.035027% of range0.1650
52W High0.1650 CAD
52W Low0.0350 CAD
Profitability
Gross Margin28.59%
Oper. Margin-194.43%
EBITDA Margin-70.38%
Profit Margin-141.06%
ROE32.58%
ROA-28.47%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.36M $
CapEx (TTM)—
FCF Margin-139.93%
FCF Yield-26.97%
Net Debt13.21M $
Net Debt/EBITDA-10.16
Balance Sheet
Debt/Equity-1.65
Current Ratio0.15
Quick Ratio0.04
Book Value/Sh-0.0550 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.187.98M
Float180.26M
Insiders13.27%
Institutions0.15%
Short Interest
Short Ratio2.3d
Short % Out.0.01%
Shares Short117.35K
Short (prev mo.)25.00K
Technical
SMA 500.0702 (-0.3%)
SMA 2000.0651 (+7.6%)
Beta0.58
S&P 52W Chg18.16%
Avg Vol (30d)38.33K
Avg Vol (10d)113.07K
Technical Indicators
RSI (14)51.9
MACD-0.0024
MACD Signal-0.0026
MACD Hist.+0.0003
BB Upper0.0772 CAD
BB Middle0.0653 CAD
BB Lower0.0533 CAD
BB Width36.51%
ATR (14)0.0076 CAD
Vol Ratio (20d)1.58x